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Summary
In the last decades, many regional and country-wide control programmes for Johne’s
disease (JD) were developed due to associated economic losses, or because of a
possible association with Crohn’s disease. These control programmes were often
not successful, partly because management protocols were not followed, including
the introduction of infected replacement cattle, because tests to identify infected
animals were unreliable, and uptake by farmers was not high enough because of a
perceived low return on investment. In the absence of a cure or effective commer-
cial vaccines, control of JD is currently primarily based on herd management strate-
gies to avoid infection of cattle and restrict within-farm and farm-to-farm
transmission. Although JD control programmes have been implemented in most
developed countries, lessons learned from JD prevention and control programmes
are underreported. Also, JD control programmes are typically evaluated in a limited
number of herds and the duration of the study is less than 5 year, making it difficult
to adequately assess the efficacy of control programmes. In this manuscript, we
identify the most important gaps in knowledge hampering JD prevention and con-
trol programmes, including vaccination and diagnostics. Secondly, we discuss direc-
tions that research should take to address those knowledge gaps.
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1 | INTRODUCTION
Johne’s disease (JD) is an infectious chronic inflammatory disorder
of the intestine in ruminants caused by Mycobacterium avium sub-
species paratuberculosis (MAP). It is a major health problem, result-
ing in intermittent diarrhoea, loss of body condition and lower
productivity (e.g., Tiwari, VanLeeuwen, McKenna, Keefe, & Barkema,
2006). In the terminal phase, which most animals will not reach due
to premature culling, animals die in very poor body condition.
Infected ruminants shed MAP in manure and milk in increasing
quantities as the disease progresses (Whitlock & Buergelt, 1996).
The disease is widespread in domestic and wild ruminant popula-
tions in almost all countries in the world and causes great economic
losses, not only because of lower productivity, but also as a result
of loss of future income due to premature culling (Garcia & Shalloo,
2015; McKenna, Keefe, Tiwari, VanLeeuwen, & Barkema, 2006).
The herd-level prevalence of MAP infection is likely >50% in most
countries with a substantial dairy industry (Barkema, Hesselink,
McKenna, Benedictus, & Groenendaal, 2010). In the absence of
control measures, JD typically spreads, as farms often purchase cat-
tle, frequently from herds with unknown JD status. In a recent
review, Garcia and Shalloo (2015) reported substantial losses due to
MAP infection, which escalate as the within-herd MAP prevalence
and incidence of clinical JD cases increase. In Canada, the economic
damage caused by JD was estimated at $50 CAN per cow per year
in MAP-infected herds, resulting in an average loss per infected
farm of nearly $3,000 CAN annually (Chi, VanLeeuwen, Weersink,
& Keefe, 2002; Tiwari, VanLeeuwen, Dohoo, Keefe, & Weersink,
2008). Raizman, Fetrow, and Wells (2009) estimated the income
over feed cost losses at $366 per MAP-shedding cow per lactation,
whereas Bhattarai et al. (2014) estimated a loss of $1,644 US per
100 cows in a herd with a true prevalence of 7%. The cost of the
disease to the US cattle industry was estimated at $250M US per
year (Ott, Wells, & Wagner, 1999).
Meta-analyses have demonstrated that the association of MAP
with Crohn’s disease in humans is specific and cannot be denied
(Abubakar, Myhill, Aliyu, & Hunter, 2008; Feller et al., 2007),
although a causal role has not yet been demonstrated (Waddell,
Rajic, St€ark, & McEwen, 2015, 2016). Furthermore, transmission
from cattle to humans has never been proven. However, addressing
JD worldwide should be considered a proactive step in ensuring con-
sumer confidence if a link was to be established between JD and
Crohn’s disease.
The epidemiology of JD is very different among cattle, sheep
and goats. These species have very distinct differences when it
comes to the course of MAP infection; therefore, inferences from
one species cannot be naively applied to other species. Production
type (e.g., dairy versus beef) also has a role in the course of MAP
infection. This is not only evident in cattle (dairy versus beef), but
probably even more evident in sheep and goats (i.e., wool/meat pro-
ducing sheep in Australia and milk producing sheep/goats in the
Mediterranean).
In this manuscript, we identify the most pressing gaps in knowl-
edge hampering JD prevention and control programmes (summarized
in Table 1). Secondly, we discuss directions that research should take
to solve these knowledge gaps.
2 | CONTROL PROGRAMMES
Due to economic losses, and its possible association with Crohn’s
disease, many control programmes for JD have been developed
worldwide. Many of these programmes focused on MAP-infected
herds and were based on testing and culling test-positive cows, plus
management adaptations (Benedictus, 1984; Collins, 1994; Kennedy,
2001; Rossiter & Burhans, 1996). The focus of some other pro-
grammes was to identify MAP-negative herds with the aim of keep-
ing these herds, and in the case of Australia, Norway and Sweden an
entire region negative, and also having them as a source of MAP-
negative replacement animals (e.g., Fr€ossling et al., 2013; Kalis, Col-
lins, Barkema, & Hesselink, 2004; Kennedy, 2011; Whist et al.,
2014). Tests included delayed type hypersensitivity (skin) tests, sero-
logical tests, direct detection of MAP by microscopy and using cul-
ture or polymerase chain reaction (PCR) to detect MAP in faecal
samples. Presently, faecal culture is considered the most sensitive
and specific ante-mortem test to identify MAP infection (Kalis, Bar-
kema, Hesselink, Van Maanen, & Collins, 2002; Whitlock, Wells,
Sweeney, & Van Tiem, 2000). However, as individual faecal culture
is expensive and time-consuming, most JD control programmes use
ELISAs to detect potentially infected animals (e.g., Lavers, Barkema,
Dohoo, McKenna, & Keefe, 2014). Another reason for using ELISAs
is that the extent of shedding correlates well with the ELISA titres
(Dargatz et al., 2001), and hence, culling ELISA positives may be an
effective and relatively low-cost option for removing high shedders.
Currently, faecal culture is often replaced with direct PCR on faeces
(e.g., Laurin, Chaffer, McClure, McKenna, & Keefe, 2015; Plain et al.,
2014).
JD control programmes have been implemented in most devel-
oped countries, with objectives based on the national economic sit-
uation of the cattle, sheep and goat industry and the herd-level
prevalence of MAP infection (reviewed by Kennedy, 2011; Ger-
aghty, Graham, Mullowney, & More, 2014). In general, objectives
include the following: (i) prove and protect freedom of disease at
the country, regional or farm-level, for example, in Norway (Whist
et al., 2014), Sweden (Fr€ossling et al., 2013) and northern and
western Australia (Kennedy, 2011); (ii) protect export of milk or
genetics, for example, Canada (McKenna, Vanleeuwen, et al., 2006);
(iii) decrease prevalence of MAP infection and limit farm-level eco-
nomic losses, for example, Denmark (Nielsen, Jepsen, & Aagaard,
2007), the UK (Pritchard, Coffey, Bond, Hutchings, & Wall, 2017),
Ireland (McAloon et al., 2016) and the USA (Wells, Hartmann, &
Anderson, 2008); (iv) eliminate or reduce MAP load in bulk milk, for
example, the Netherlands (Weber & van Schaik, 2007); and (v) elim-
inate MAP infection, for example, Norway in goats (Nagel-Alne
et al., 2014).
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Some factors that hampered the success of such control pro-
grammes were lack of compliance with management protocols, use of
tests with a sufficiently high sensitivity to identify infected cattle,
persistence of MAP in the environment, inadequate test frequency,
appearance of unexpected new infections and purchase of replace-
ment animals causing new introductions (Benedictus, 1984; Collins,
2001). A complementary modelling study showed that consistent
application of preventive measures was key to success, although only
“test and cull” was not crucial to control JD (Groenendaal, Nielen, &
Hesselink, 2003). However, “test and cull” can support and hasten
elimination of infection from a herd that also has good management
practices (Kudahl, Nielsen, & Ostergaard, 2011). Because there is no
cure and, except for sheep, there are no vaccines that effectively pre-
vent MAP infection, control of JD is currently based primarily on herd
management strategies that reduce the risk of infection in young
calves and restrict within-farm and farm-to-farm transmission.
TABLE 1 Most important knowledge gaps that hamper prevention and control of Mycobacterium avium subspecies paratuberculosis (MAP)
infection
Area Knowledge gap
Control programmes  (Long-term) efficacy of control programmes
 Is eradication of MAP infection in a herd possible?
Prevalence  Comparison of MAP prevalence over time in the same region
 Comparison of prevalence in different regions using the same test (regime)
The pathogen  Distribution of MAP genotypes
 Differences in virulence, pathogenicity, immunogenicity, persistence, transmission, survival outside the
host and host specificity between genotypes
 Effect of mixed genotype infections and superinfections
Tests  Characteristics of tests in a population that reflects the target population
 Development of reliable early-stage diagnostics
 Reliable on-farm tests
 Value of detection of immunoglobulin isotypes other than IgG
 Most accurate and cost-effective set of environmental samples and sampling interval (dairy)
 Best DNA extraction protocols for PCR analyses
 How to quantify MAP in tissues, blood, milk and faeces
 Validation of biomarkers in naturally infected cattle
Transmission  Role of MAP-shedding young stock
 Relative importance of various transmission routes (including transmission through dust and drinking water)
 Influences on survival of MAP in soil and on pasture)
 Minimal infectious dose for animals of all ages
 Consequence and importance of intrauterine transmission
 Shedding pattern of MAP-infected animals, including role of supershedders
 Effectiveness of commercial pasteurizers at reducing viable MAP bacteria in colostrum
Role of wildlife  Validation of diagnostic tests for wildlife
 Prevalence of MAP in wildlife
 Impact of MAP infections on wildlife health
 Magnitude of the role wildlife plays as MAP reservoir and in transmitting MAP to farmed animals
 Economic benefits of reducing MAP transmission from wildlife to livestock
Susceptibility  Influences on susceptibility and the progression of MAP infection (e.g., age, genetics)
 Genetic heritability of MAP infection
 Difference in susceptibility among breeds
 Identification of genetic markers associated with MAP susceptibility, disease progression and response to vaccination
 Benefit of the IFN-c assay in genetic linkage studies
 Interaction between host genotype and MAP genotype
Vaccination  Development of a cattle vaccine that limits infection and/or shedding, and does not interfere with diagnostics for
other mycobacterial infections
 Better understanding of immune evasion and immune modulation strategies of MAP
 Characterization of diversity of MAP strains to select the most appropriate vaccine strain
 Definition of protective immune response by vaccination
 Appropriate level of attenuation of vaccine strains to elicit immune response without causing disease
 Differentiation between infected and vaccinated animals
Uptake  Influences on farmers’ motivation to enrol in (voluntary) disease prevention and control programmes and
implement recommended management strategies
 How to overcome the “wait-and-see” mindset
 Veterinary practitioners’ role in promoting control programme participation including communication
 Potential of approaches that address Johne’s disease in combination with other faecal-orally transmitted diseases
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Additionally, control programmes which include testing of individual
animals, in general advise culling of MAP-positive animals.
Although JD control programmes have been implemented in
most developed countries, the lessons learned from the actual expe-
rience with JD prevention and control programmes are underre-
ported worldwide. JD control programmes are typically evaluated in
a small number of herds (e.g., Collins, Eggleston, & Manning, 2010;
Pillars, Grooms, Gardiner, & Kaneene, 2011), and many cattle control
programmes have not included beef cattle. Additionally, particularly
in cattle, results of a JD control programme can only be judged after
at least 5 y (Caldow & Gunn, 2001; Nielsen & Toft, 2011), although
most of the current well-designed programmes have been imple-
mented that long (Table 1). Except for goats in Norway (Nagel-Alne
et al., 2014), no report could be found in a herd in which MAP infec-
tion has successfully been eradicated (Table 1). There are many
explanations for this failure which are discussed in the following sec-
tions.
Finally, some programmes were implemented but abandoned due
to the outbreak of another disease (e.g., bovine spongiform
encephalopathy or foot-and-mouth disease) or loss of funding (e.g.,
USA and Alberta, Canada), making it difficult to regain trust and re-
institute the programme.
3 | PREVALENCE
It is essential that reliable estimates of disease prevalence (animal or
herd level) are available as this will determine how to proceed and
monitor the results of a control programme over time. The goals
may vary from eradication in areas of low prevalence, control in
areas with high prevalence or increased surveillance in an area with
no prior history of disease. Prevalence estimates obtained by surveys
are affected by test accuracy; therefore, comparisons among studies
must be adjusted to better estimate the true prevalence.
Infection with MAP and cases of JD have been reported from
all continents with ruminant populations. Prevalence in most
regions is currently unknown, and prevalence studies have low
design uniformity, making comparisons among regions unreliable
due to different sampling strategies and case definitions. Addition-
ally, in most studies, the true herd-level prevalence and animal-level
prevalence have not been estimated. Thus, the results of these
studies and the reported prevalence estimates of MAP infection
can currently not be compared directly (Table 1). Additionally, in
most regions, herd-level prevalence and animal-level prevalence are
underestimated, as the sensitivity of ELISAs is overestimated, par-
ticularly for cattle in 1st lactation heifers (McKenna, Keefe, Bar-
kema, & Sockett, 2005; McKenna, Sockett et al., 2005; Nielsen &
Toft, 2008). Almost invariably, in regions where herd-level preva-
lence estimates were obtained using an ELISA and independently
validated using faecal culture or environmental culture, true preva-
lence estimates (adjusted for test characteristics) are much lower
based on testing with ELISA versus culture (e.g., Lavers et al.,
2014; Wolf et al., 2014). Although MAP test comparisons have
been the subject of many studies, there is a lack of studies com-
paring test characteristics in populations that reflect the target pop-
ulation when estimating the prevalence of MAP infection (Nielsen
& Toft, 2008). The sensitivity of MAP tests increases in dairy cattle
with increasing days in milk and age but decreases with increased
milk yield (Eisenberg, Veldman, Rutten, & Koets, 2015; Kirkeby,
Græsbøll, Halasa, Toft, & Nielsen, 2015), whereas sensitivity
increases with age in sheep and goats (Lybeck, Storset, Djønne,
Valheim, & Olsen, 2011). Therefore, sensitivity estimates need to
be adjusted for age in all ruminants, and days in milk and milk yield
in dairy cattle when comparing between or within herds and also
over time.
Comparing prevalence over time, among regions and countries is
often unreliable due to the use of a variety of diagnostic tests, often
with unknown or unreliable test characteristics. To compare herd-
and animal-level prevalence estimates of MAP among countries, and
to allow for the development of international trade standards, we
recommend a supranational standardized study, comparable to a
Neospora caninum seroprevalence study involving cattle from four
countries (Bartels et al., 2006) (Table 1).
4 | THE PATHOGEN
Strain typing is useful in helping to clarify epidemiological and viru-
lence questions that cannot otherwise be resolved; however, limited
genetic variation among MAP isolates within host species has slo-
wed progress. Several typing techniques have been used (Amonsin
et al., 2004; Coffin et al., 1992; Collins & de Lisle, 1986; Motiwala
et al., 2003; Thibault et al., 2007; Whittington, Hope, Marshall, Tara-
gel, & Marsh, 2000; Whittington, Marsh, Choy, & Cousins, 1998).
Whole-genome sequencing (WGS), because of its higher resolution,
is the logical evolution of technology to assist epidemiological inves-
tigations and control programmes. The cost of WGS still has to
decrease though for this technique to become the technique of
choice in this kind of studies.
Variable number tandem repeat (VNTR) and mycobacterial inter-
spersed repetitive unit (MIRU) typing have been moderately success-
ful for characterizing MAP isolates. Diversity among isolates has
been reported based on VNTR typing (Fritsch, Luyven, K€ohler, Lutz,
& M€obius, 2012; Sohal et al., 2014; Stevenson et al., 2009; Thibault
et al., 2008), with most isolates being one of two dominant VNTR
types. MIRU-VNTR genotyping does not, however, accurately reflect
phylogenetic relationships, and repeat sequences are subject to
homoplasy (Ahlstrom, Barkema, & De Buck, 2014; Bryant et al.,
2016). Current VNTR typing includes loci that are too unstable and
unreliable to be used for a molecular epidemiological analysis of
MAP (Ahlstrom et al., 2015). Short sequence repeat (SSR) typing
(Amonsin et al., 2004) further differentiates MAP isolates of the
same VNTR type (Stratilo, Lewis, Bryden, Mulvey, & Bader, 2006;
Thibault et al., 2008) but lacks sufficient discrimination and stability
for epidemiological studies (Kasnitz, K€ohler, Weigoldt, Gerlach, &
M€obius, 2013). Nevertheless, in specific cases, VNTR (with or
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without SSR typing) can still be useful for supporting source tracing
investigations and JD control measures (Oakey, Gavey, Singh, Platell,
& Waltisbuhl, 2014).
Whole-genome sequencing (WGS) provides unparalleled detail
regarding genetic profiles of MAP. Genomic epidemiology of MAP is
new (Ahlstrom et al., 2015, 2016) but has already provided impor-
tant insights into transmission dynamics. Single nucleotide polymor-
phisms (SNPs) identified through WGS are evolutionarily stable and
can be reliably used to identify true evolutionary relationships (Pear-
son, Okinaka, Foster, & Keim, 2009). In a MAP-endemic environ-
ment, this level of detail is invaluable in understanding the molecular
epidemiology and transmission dynamics. For example, there are at
least eight genetically distinct MAP subtypes in Canadian dairy cat-
tle, with >80% of isolates belonging to a single dominant subtype
(Ahlstrom et al., 2016). However, this information cannot be extrap-
olated to other countries because dominant strains vary between
countries and continents (Kiehnbaum, Amonsin, Wells, & Kapur,
2005; Machackova et al., 2004; Motiwala et al., 2004; Whipple,
Kapke, & Vary, 1990). Some strains may be more successful in
spreading or persisting in different environments or management
systems. It is difficult to know whether high MAP prevalence within
a specific herd relates to a high MAP infection opportunity (e.g.,
poor biosecurity) or is due to MAP strains with increased transmis-
sion potential on these farms.
Strain typing can be used to track transmission of MAP in a vari-
ety of settings and host species. Studies of within-herd spread of
MAP infection (Pradhan et al., 2011), between-herd transmission
(Oakey et al., 2014) and the role of wildlife in spreading MAP
(Fritsch et al., 2012) require molecular tools that can differentiate
MAP types. WGS was recently used to identify multiple mixed geno-
type infections (Davidson, Ahlstrom, De Buck, Whitney, & Tahlan,
2016); these infections could affect disease dynamics and impact
pathogen evolution and genetics and thereby impact the efficacy of
therapeutic treatments or vaccines (Table 1).
An understanding of the full genetic diversity of MAP is needed
to accurately assess subtype-specific phenotypes and virulence char-
acteristics, and to develop vaccines and effective management prac-
tices (Table 1). Investigations into strain-specific differences in MAP
virulence and pathogenicity have been mostly limited, however, to
major strain types (Borrmann, M€obius, Diller, & K€ohler, 2011; Goll-
nick et al., 2007; Janagama, Jeong, Kapur, Coussens, & Sreevatsan,
2006; Motiwala et al., 2006), with significant differences between
Types I and II isolates reported for growth rates and intracellular sur-
vival (Table 1).
Investigations have determined phenotypic differences among
MAP subtypes for a variety of traits, including growth rates and inva-
sion efficiencies, immunogenicity, virulence as measured by macro-
phage invasion efficiencies and kinomic responses (Griebel et al.,
2014; Whittington et al., 2011). Future vaccine development and
molecular epidemiological studies should also consider the relative
frequencies of MAP subtypes with a focus on dominant subtypes.
There are differences among MAP strains in the immune response
that they stimulate, as well as differences in host tropism, disease
phenotypes and ability to evade control by vaccines (Colavecchia
et al., 2016; Sohal, Singh, Singh, & Singh, 2010) (Table 1).
5 | TESTS
5.1 | Purpose of testing
Test results used in control programmes should primarily assist deci-
sion-makers achieve a specific objective. Furthermore, the specific
test strategies employed are likely to differ between regions,
depending on the logistics of implementation and other practicalities,
as well as herd size (Dorshorst, Collins, & Lombard, 2006). Identifica-
tion of infected animals before they spread the infection while still
maximizing the lifetime production of an animal is the goal of a cost-
effective test strategy. Purposes of testing primarily include the fol-
lowing: (i) estimate infection prevalence to determine the best
course of action; (ii) minimize financial losses as a result of impaired
milk production or growth and increased culling rate; (iii) estimate
the effects of proposed control measures or evaluate additional mea-
sures or management changes; (iv) eliminate infectious cattle to
reduce spread of infection, (v) reduce the risk of MAP contamination
of food products for human consumption; and (vi) eradicate MAP
from a herd (or region). Tests for these purposes can focus on indi-
vidual animals, herds or a subset of the herd. Control strategies that
focus on the individual animal- and target-specific management con-
ditions contributing to transmission include the following: (i) identifi-
cation of infectious animals actively shedding MAP; and (ii)
identification of infected animals at risk of shedding MAP (Table 1).
Ideal tests used for control should identify the infectious animal
or predict its infectivity. However, as we do not know the infectious
dose of MAP, shedding patterns of infected animals and factors con-
tributing to disease progression, it is difficult to interpret test results
(Table 1). Consequently, we struggle to identify MAP infection cases
and non-cases, which is essential when evaluating the accuracy of
diagnostic tests. This has resulted in decades of reported test evalua-
tions that are of questionable quality (Nielsen & Toft, 2008).
Existing tests are performing reasonably well in detecting
advanced stages of JD, although the specificity of test results may
be challenged and the number of bacteria excreted in faeces or milk
is rarely quantified. Detection of early-stage infection is only of
interest for a control programme if these animals then become infec-
tious (Marce, Ezanno, Seegers, Pfeiffer, & Fourichon, 2011). Other-
wise, these infections may disappear from a specific population.
However, because the sensitivity of diagnostic tests in calves is gen-
erally low, young stock are rarely tested for MAP. As a result, no
longitudinal studies have been published that followed infected
calves or lambs and confirm how many subsequently test positive
(Table 1).
5.2 | Early-stage diagnostics
Early-stage diagnostics primarily target pro-inflammatory immune
responses. To be useful, however, they should differentiate infected
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from recovered animals (Dennis, Reddacliff, & Whittington, 2011)
and indicate if or when an animal will become infectious (de Silva
et al., 2013). Whereas detection of faecal shedding by direct extrac-
tion followed by a MAP-specific PCR can detect if an animal is infec-
tious (Fock-Chow-Tho, Topp, Ibeagha-Awemu, & Bissonnette, 2017),
it cannot indicate whether or when it will become infectious. Such a
test would likely be useful to achieve eradication in low prevalent
populations (Table 1).
Identification and multiplexing of antigens that elicit an early
humoral immune response could yield a serological test that over-
comes the current delay in antibody-based detection of MAP infec-
tion. Analyses of longitudinal serum samples (from experimentally
infected calves) were used to detect developing humoral immune
responses against MAP proteins (Bannantine et al., 2008), with anti-
MAP antibodies detected as early as 70 day after infection. Novel
MAP antigens for detection of antibody responses in subclinical cat-
tle were also reported (Facciuolo, Kelton, & Mutharia, 2013).
The interferon-gamma (IFN-c) assay detects cell-mediated
immune responses to early-stage MAP infection (Stabel, 2000), but
needs improvements and standardization as differences in composi-
tion of the purified protein derivative (PPD) antigens can influence
specificity (Capsel et al., 2016; Kalis, Collins, Hesselink, & Barkema,
2003). Single proteins to increase specificity of T-cell responses are
being sought (Carlos et al., 2015; Huygen, 2014; Leite, Reinhardt,
Bannantine, & Stabel, 2015; Rana, Rub, & Akhter, 2015). Blood sam-
ples must be tested within 8 hr for optimal results to ensure T-cell
viability, although IL-12 and anti-IL-10 supplementation (Mikkelsen,
Aagaard, Nielsen, & Jungersen, 2012) or IL-7 and IL-12 supplementa-
tion (Plain, Begg, de Silva, Purdie, & Whittington, 2012) can increase
the interval to 48-hr interval before testing. Ultimately, an on-farm
test would be most effective.
Leucocyte markers associated with MAP infection may also be
used as a diagnostic test. For example, increased expression of
CD25 and CD45RO on T cells may be an early indication of infec-
tion (Stabel & Robbe-Austerman, 2011), but these markers lack
specificity. Furthermore, phenotype analysis of leucocytes is again
dependent upon the isolation and analysis of viable cells. The lack of
useable and rapid diagnostic tests for specific biomarkers is clearly a
bottleneck in identifying animals with MAP infection.
To accommodate the discovery of biomarkers that can predict
the onset of the infectious stage, experimental infection models pre-
senting a natural disease outcome (e.g., Begg et al., 2010; Mortier
et al., 2013) are essential for test development (Begg & Whittington,
2008; Hines et al., 2007). Ultimately, longitudinal sampling of herds
with different prevalence profiles is necessary to validate the out-
comes of experimental infections in an unbiased and representative
set of samples from infected but not yet infectious animals.
5.3 | Late-stage diagnostics
Late-stage diagnostic tests detect anti-inflammatory immune
responses, for example, ELISAs detecting IgG1. They are relatively
well characterized and easy to automate, but sensitivity is in general
still low compared to viral infections, such as bovine leukosis (Niel-
sen & Toft, 2008). Ideally, these should be reliable point-of-care
tests using blood or milk from individual cows (Lavers et al., 2014)
(Table 1). Better characterization of disease progression in relation
to the induction of IgG1 antibody responses is desired.
There might be value in the detection of immunoglobulin iso-
types other than IgG (e.g., IgM and IgA) (Table 1). Although IgM is
the first isotype to appear in response to an infection, this response
has limited applicability as it transient (Abbas & Riemann, 1988). Iso-
type switching results in local mucosal production of IgA and anti-
MAP IgA responses have been detected in faecal samples from
infected sheep (Begg et al., 2015). The challenge remains the identi-
fication of individual MAP proteins that detect antibodies specific to
MAP and not environmental Mycobacterium spp.
Calves, kids and lambs were reported to be ELISA positive for
MAP 3–4 month after infection (Kurade, Tripathi, & Rajukumar,
2004; Mortier, Barkema, Orsel, et al., 2015; Storset et al., 2001).
However, in very young animals, such ELISA antibodies may be an
indication of passive immunity (transfer of colostrum-derived mater-
nal antibodies), as maternal antibodies reacting with MAP were
detected in serum collected from calves up to 121 d of age (Schillin-
ger et al., 2013).
The titre of an ELISA is predictive for the probability of MAP
shedding (Weber & van Schaik, 2007). This association renders the
utility of an ELISA as highly applicable to JD control in dairy herds
when the aim is to reduce transmission by selective removal of
shedders. In that instance, an ELISA may replace faecal culture or
PCR, but it is then important to shorten the testing interval (Lu
et al., 2008).
5.4 | Herd-level diagnostics
Environmental sampling is a quick sampling method to determine the
MAP infection status of a herd (Wolf et al., 2017). However, this
sampling method is only sufficiently sensitive in relatively intensive
livestock operations such as housed dairy cattle. In extensive farm-
ing, such as sheep and cow-calf herds in many countries, environ-
mental sampling currently does not have sufficient sensitivity
(Whittington et al., 2003). For example, culture followed by PCR on
six environmental samples detected 70% of MAP-infected dairy
herds (Wolf, Barkema, De Buck, & Orsel, 2015). Samples collected
from alleyways of lactating cow pens and manure lagoons were most
sensitive (Wolf, Barkema, et al., 2015). On farms with only manure
piles (or if an outdoor lagoon is inaccessible due to weather), addi-
tional samples should be collected from indoor manure pits or alley-
ways. In a recent German study in cow-calf herds, environmental
samples collected in high cow traffic areas at the end of the winter
had a sensitivity of 64% (Klawonn, Einax, P€utzschel, Schmidt, &
Donat, 2016), which is similar to housed dairy herds (Wolf et al.,
2017). There is certainly room for improvement of environmental
sampling; modifications in the number of collected samples per set
and in sampling intervals may result in more accurate diagnostic pro-
tocols (Table 1). Further refinements of environmental sampling,
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including determining impact of season, are needed (Wolf, Barkema,
et al., 2015). Culture of pooled faecal samples, most often consisting
of pools of 5 or 10 for cattle, or 10 to 50 for sheep faecal samples,
has been extensively evaluated and proven to be relatively sensitive
(Sergeant, Whittington, & More, 2002; Van Schaik, Pradenas, Mella,
& Kruze, 2007; Verdugo, Jones, et al., 2014; Whittington, Fell, et al.,
2000).
Processing pooled environmental samples with direct PCR
instead of culture reduces processing time and costs (B€olske &
Herthnek, 2010). An additional advantage of PCR compared to cul-
ture is that PCR is not dependent on viable MAP bacteria in the
sample. That might result in a higher sensitivity with PCR, especially
if samples are collected in the winter, or at locations where manure
accumulates over extended times. Test characteristics for PCR (typi-
cally using IS900 or F57 as the target) relative to culture have been
reported, with overall good results (e.g., Clark, Koziczkowski, Radcliff,
Carlson, & Ellingson, 2008; Cook & Britt, 2007; Fock-Chow-Tho
et al., 2017) for both pooled and environmental samples (e.g., Kawaji,
Taylor, Mori, & Whittington, 2007; Mita et al., 2016). Results are,
however, highly depend on the extraction method and the primer(s)
used (Mita et al., 2016) (Table 1).
Testing of bulk tank milk or a pool (whole herd set of Dairy Herd
Improvement milk samples) using a commercial ELISA is an inexpen-
sive method of herd screening for JD in dairy cattle (Kelton et al.,
2014). To determine a herd’s MAP infection status, bulk milk sam-
ples can either be analysed for the presence of MAP-specific anti-
bodies using ELISA, or for the presence of MAP bacteria using direct
PCR. Although repeated bulk tank test results are consistent over
short intervals and correlated with herd prevalence (Nielsen & Toft,
2014), results can be influenced by herd size and within-herd preva-
lence of ELISA-positive individuals. This testing identifies herds with
moderate (>5% within-herd milk ELISA positive) to high (>8% within-
herd milk ELISA positive) prevalence (Serraino et al., 2014). This test
is not sensitive enough to detect low prevalence herds (Jayarao
et al., 2004; Khol et al., 2013; Van Weering et al., 2007) or to moni-
tor subtle changes in within-herd prevalence over time.
As is the case with all JD testing strategies, given the low sensi-
tivity of the tests, the proportion of infected herds is underestimated
and negative test results can give dairy producers a false sense of
security based on the belief that a negative test means their herd is
uninfected. However, with increasing frequency statistical tools such
as Bayesian statistics are used to correct for less than ideal test
characteristics that are predominantly the result of the biology of
MAP infection (e.g., McAloon et al., 2016; Verdugo, Pleydell, et al.,
2014; Verdugo, Jones, et al., 2014).
5.5 | Recent developments and future directions
Novel findings and approaches in diagnostic test development and
evaluations are rare, and so far no major breakthroughs have been
provided. Mostly, incremental improvements to existing tests and
test strategies have been identified, for example, repeated testing in
a Danish JD control programme (Nielsen, 2008). Once prevalence is
reduced, cost-effective monitoring of the MAP status of a popula-
tion can be difficult. Development of cost-effective strategies for
surveillance and certification is still required while retaining a focus
on the fit-for-purpose criterion (OIE, 2012).
Quantitative PCR (qPCR) for assessing the number of MAP bac-
teria in faeces has great promise in comparison with bacterial culture
(Christopher-Hennings et al., 2003; Khare et al., 2004; Kralik, Beran,
& Pavlik, 2012; Laurin et al., 2015) (Table 1). This technique has
been validated on spiked faecal samples and proficiency panels,
including faecal samples from naturally infected animals (e.g., Plain
et al., 2014). This approach is strongly dependent on efficient DNA
extraction, which has been studied (summarized in B€olske & Herth-
nek, 2010). However, quantification by qPCR is still only a relative
method because a standard curve of spiked samples needs to be
used to determine the approximate copy number of MAP organisms
in a test sample. Digital (third-generation) PCR is expected to be
more quantitative, more precise and predict absolute numbers of
shed bacteria in faeces and therefore be useful to validate other
tests and biomarkers as has been studied for Mycobacterium tubercu-
losis (Devonshire et al., 2016). microRNAs circulating in blood may
provide another a promising method to detect MAP infection
(Shaughnessy, Farrell, Riepema, Bakker, & Gordon, 2015), but this
has not been confirmed.
The effect of MAP genotype on disease progression, shedding,
immune responses or generation of other biomarkers is not well
characterized (Table 1). A longitudinal follow-up of animals by ELISA,
IFN-c testing, faecal culture and eventually tissue culture is needed.
Using proteomic and transcriptomic analyses, several putative
biomarkers for early infection with MAP have been proposed (Casey
et al., 2011; David, Barkema, Luo Guan, & De Buck, 2014; David,
Barkema, Mortier, et al., 2014; Seth et al., 2009; Shin et al., 2015;
Skovgaard et al., 2006; Thirunavukkarasu et al., 2014; You et al.,
2012; Zhong, Taylor, Begg, & Whittington, 2011). Metabolomic pro-
filing detected MAP infection earlier than other diagnostic methods,
with individual metabolites distinguishing infected from non-infected
cattle (De Buck, Shaykhutdinov, Barkema, & Vogel, 2014). Further-
more, changes in faecal microbiota of MAP-infected cattle may have
promise for identifying infected animals during subclinical stages of
JD (Derakhshani et al., 2016). Analysis of volatile organic compounds
emitted during culture may assist in identifying growth and also
strain identification (Trefz et al., 2013). These and other emerging
diagnostic technologies and approaches have recently been reviewed
by Britton, Cassidy, O’Donovan, Gordon, and Markey (2016). Unfor-
tunately, none of these biomarkers have been properly validated on
naturally infected cattle of varying ages or in various stages of infec-
tion to reveal their true sensitivity and specificity (Britton et al.,
2016) (Table 1).
6 | ROUTES OF TRANSMISSION
MAP can be transmitted by: (i) ingestion of faecal material, (ii) drink-
ing contaminated colostrum or milk, (iii) intrauterine infection and,
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potentially, (iv) aerogenic transmission. The best method to prevent
transmission is expected to be limiting exposure of calves to adult
faeces by systematic separation of adult cows and calves, in combi-
nation with good hygiene practices (Marce et al., 2011).
There are limited data regarding the quantity of bacteria shed by
animals in the different infection stages (Marce et al., 2010; Whit-
tington, Reddacliff, Marsh, McAllister, & Saunders, 2000), with sub-
stantial inter- and intra-animal variability (Crossley, Zagmutt-Vergara,
Fyock, Whitlock, & Gardner, 2005; Whitlock et al., 2000). However,
recent advances in PCR technologies (digital droplet PCR; Pinheiro
et al., 2012) should enable a determination of the exact number of
organisms associated with the different modes of transmission (fae-
ces, milk, colostrum) for all different stages of infection (susceptible/
uninfected, transiently infectious, latently infected, infectious, resis-
tant stages) (Table 1). This knowledge would be especially meaning-
ful if in parallel the corresponding infectious dose and the
corresponding infection risk associated with the various transmission
routes were determined for animals of all ages. However, it is impor-
tant to note that single inoculations may be a poor model of natural
infection as the frequency of exposure might be an important factor
in transmission. Typically, several or consecutive-day inoculations are
used (Begg et al., 2010; Hines et al., 2007). However, a trickle dose
(limited numbers of organisms) was highly effective in causing
intestinal infection (Eisenberg et al., 2011), suggesting that more
complex dynamics play a role during natural infections and need to
be taken into account for a better understanding of transmission and
infection.
6.1 | Colostrum
Milk and colostrum can be contaminated with MAP, either through
faecal contamination of teats or shedding from the udder (Stabel &
Goff, 2004; Streeter, Hoffsis, Bech-Nielsen, Shulaw, & Rings, 1995;
Sweeney, Whitlock, & Rosenberger, 1992). In a Danish study, calves
that received colostrum from multiple cows had 1.24 times the odds
of testing MAP ELISA positive as adults compared to cows that only
received colostrum from their dam (Nielsen, Bjerre, & Toft, 2008). In
contrast, the risk of infection from ingestion of colostrum was
recently challenged in a cohort study concluding that MAP-contami-
nated colostrum did not increase the risk of MAP shedding in calves
up to two years of age (Eisenberg, Rutten, & Koets, 2015). This
reveals a knowledge gap regarding transmission and certainly the rel-
ative contribution of some transmission routes (Table 1).
A reduction in within-herd prevalence of MAP infection may be
achieved by pasteurizing colostrum to reduce MAP transmission.
Heat treatment reduces the number of viable MAP bacteria in milk
(Eltholth, Marsh, Van Winden, & Guitian, 2009; Lund, Gould, & Ram-
pling, 2002). However, most studies used huge numbers of bacteria,
spiked milk (not naturally infected), milk instead of colostrum and a
hot water bath, not a commercial pasteurizer. Therefore, the current
knowledge is insufficient to answer the question whether on-farm
pasteurization using commercial pasteurizers can effectively reduce
the number of viable MAP bacteria in colostrum (Table 1).
6.2 | Calf-to-calf
Cattle farmers typically try to interrupt faecal–oral transmission by
implementing best-hygiene management practices. In many studies,
there were associations between specific management practices and
the likelihood of animals being infected with MAP (e.g., Nielsen &
Toft, 2011); however, many questions remain unanswered. In partic-
ular, the potential risk of calf-to-calf transmission is largely over-
looked in JD prevention and control programmes; only one of eight
MAP modelling studies included calf-to-calf transmission (reviewed
by Marce et al., 2010) (Table 1). Although many researchers associ-
ate a low risk with this potential transmission pathway, based on the
assumption that calves will not shed MAP in their faeces (Groenen-
daal et al., 2002; Marce et al., 2011), there is strong evidence of
calves being infected by other calves (Benedictus et al., 2008; Van
Roermund, Bakker, Willemsen, & de Jong, 2007; Wells & Wagner,
2000). One reason for these apparently discordant results is the dif-
ficulty in establishing an exposure–disease relationship, due to the
delayed clinical onset of JD (Collins, 1996). Benedictus et al. (2008)
reported that calf-to-calf transmission occurs, and that contact with
infectious animals increases the likelihood of calves being infected
with MAP, which supports previous data (Van Roermund et al.,
2007). Unfortunately, this study (Benedictus et al., 2008) was carried
out on a single farm and outcomes were measured long after expo-
sure. Consistent with some studies (Bolton, Grooms, & Kaneene,
2005; Santema et al., 2012; Van Roermund et al., 2007; Weber,
Kogut, Bree, & Van Schaik, 2006), in a recent challenge experiment
on age- and dose-dependent susceptibility (Mortier et al., 2013),
47% of calves with a proven MAP infection shed the bacterium at
least once from 2 to 6 mo after infection (Mortier, Barkema, Orsel,
Wolf, & De Buck, 2014). In a recent study, co-mingling MAP-
infected and non-infected calves for 3 mo resulted in infection of
50% of the na€ıve calves (Corbett, De Buck, Orsel, & Barkema, 2017).
It was estimated that under the circumstances of the study, one
MAP-infected calf on average infected three other calves. Addition-
ally, on 17 MAP-infected dairy farms in Alberta, Canada, 3% of
calves were shedding the bacterium, and on nine of these farms,
MAP-positive environmental samples were collected from young
stock pens (Wolf, Orsel, De Buck, & Barkema, 2015). Due to acidi-
fied milk feeding and automatic milk feeders (Barkema et al., 2015),
many dairy calves are group-housed both before and after weaning.
Consequently, there is a need for longitudinal studies quantifying the
risk of MAP transmission among calves by measuring MAP shedding,
environmental contamination and tissue levels in naturally infected
calves (Table 1). If calf-to-calf transmission is deemed important, JD
prevention and control programmes will require modifications.
6.3 | Intrauterine
Some calves from MAP-infected cows are infected at birth (reviewed
by Whittington & Windsor, 2009). Intrauterine infection is more
likely in cows with clinical JD (Whittington & Windsor, 2009) and
may be lower in herds with a low MAP prevalence (Adaska &
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Whitlock, 2012). Most studies that determined the proportion of
intrauterine infection with MAP recovered foetuses of MAP-infected
cows at various stages of pregnancy (Whittington & Windsor, 2009).
As many of these foetuses were recovered prior to term, the propor-
tion of calves born with a MAP infection is undoubtedly underesti-
mated. Additionally, it is not known if or when intrauterine infected
calves will start shedding, how infection progresses, and the nature
of the immune response, compared to calves infected orally soon
after birth (Table 1). The rate of 15% intrauterine infections may
have been overestimated as a new analysis suggested it may only be
4% (Mitchell et al., 2015).
Intrauterine transmission from dam to foetus appears to be more
common in red deer than in cattle and sheep, with 90% of clinically
affected hinds having an infected foetus (Van Kooten, Mackintosh, &
Koets, 2006). In another study, MAP was isolated from 78% of foe-
tuses from 18 subclinically infected seropositive red deer hinds
(Thompson, Clark, & Mackintosh, 2007). By contrast, MAP was iso-
lated from only 39% of foetuses from clinically affected dairy cows
and 9% of foetuses from subclinically infected cows (Whittington &
Windsor, 2009). In sheep, intrauterine transmission is thought to
occur in <10% of infected ewes. Intrauterine transmission of MAP
has also been detected in free-ranging red deer and chamois (Deutz,
Spergser, Wagner, Rosengarten, & K€ofer, 2005). As in cattle, MAP-
infected colostrum and milk may cause pseudo-vertical transmission
in deer and other wildlife.
6.4 | Environment
If a cow is shedding MAP in the faeces, her manure is infectious and
can remain so for at least 1 y (Whittington, Marshall, Nicholls,
Marsh, & Reddacliff, 2004). The proportion of environmental manure
samples that are culture-positive increases with an increasing preva-
lence of MAP-infected cows (Wolf, Barkema, et al., 2015). In sheep,
shedding is dose- and age-at-infection dependent (McGregor, Dhand,
Dhungyel, & Whittington, 2012). However, sheep of all ages and
exposed at all doses are equally likely to be colonized by MAP,
although the severity of histopathological lesions was strongly deter-
mined by age at exposure (McGregor et al., 2012). These findings
stress the role of transmission at pasture, especially for young ani-
mals.
There is a need for more research to investigate the role of envi-
ronmental transmission taking into account the survival characteris-
tics of MAP and the contact structure between animals in a herd
(Table 1). Survival of MAP in the environment has been suggested
to depend on many factors, including soil pH, faecal content, con-
centrations of macro- and micronutrients (e.g., Fe, Mo and Cu), tem-
perature and exposure to sunlight (reviewed by Elliott, Hough,
Avery, Maltin, & Campbell, 2015). No viable (culturable) MAP was
detected after 2 month of anaerobic digestion at a farm-scale biogas
plant (Slana, Pribylova, Kralova, & Pavlik, 2011). MAP was present in
settled dust samples on dairy farms under both experimental and
field conditions (Eisenberg, Koets, et al., 2010; Eisenberg, Nielen,
et al., 2010). Although current JD prevention programmes do not
consider dust, it could be a fomite and facilitate transmission (Cor-
ner, Pfeiffer, & Abbott, 2004) (Table 1).
The results of many of the studies on survival in the environ-
ment are very difficult to generalize to different environmental cir-
cumstances (Elliott et al., 2015) and MAP strain types (Whittington
et al., 2004) (Table 1). Secondly, most studies were carried out as an
experimental model and not as a field study. Also, because it is not
clear what dose of viable MAP will lead to infection in animals of
different age groups, it is not clear whether ingestion of the surviv-
ing concentration of MAP bacteria would actually lead to a MAP
infection. Additionally, it is not clear whether these factors only
influence survival and/or virulence of MAP bacteria, or whether
there might also be an influence on the host, through (in)direct
effects of these factors on the immune system (Lugton, 2004).
Finally, management practices relevant to the transmission of MAP
may be associated with environmental factors such as soil type,
exposure to sunlight and humidity (Table 1).
6.5 | Within-herd transmission
Understanding the routes of MAP transmission between cattle is
very important for effective control of the disease. The best-estab-
lished transmission route of MAP is oral uptake of bacteria by sus-
ceptible young stock, via colostrum, milk, water or food
contaminated with faeces from MAP-shedding animals (Benedictus
et al., 2008; Sweeney, 1996). In addition, intrauterine transmission
has been described.
Although isolation of adult cattle from young calves has an
important role in prevention of JD (Groenendaal et al., 2002), after
20 year of management and hygiene measures to prevent MAP
transmission in a dairy herd, complete eradication was not achieved,
implicating other non-identified and therefore non-controlled trans-
mission routes (Table 1). In sheep, experimental intratracheal intro-
duction of MAP caused infection (Kluge et al., 1968), whereas
intestinal infection occurred after exposure to MAP-containing aero-
sols given intratracheally and intranasally (Eisenberg et al., 2011). As
MAP has been detected in bioaerosols on dairy farms, transmission
of MAP by bioaerosols should be further studied including estima-
tions of the relative contributions of the various transmission routes
identified. Additionally, there is evidence that infection of non-lactat-
ing heifers or adult cows can occur (e.g., Fecteau, Whitlock, Buergelt,
& Sweeney, 2010), likely when infection pressure is high.
All existing recommendations (McKenna, Vanleeuwen, et al.,
2006) for decreasing the risk of new infections of MAP in a dairy
operation are meant to reduce infection rates in calves by decreasing
contact with adult cows. Regardless, a better understanding of trans-
mission and increased testing should improve disease control
(Table 1).
6.6 | Between-herd transmission
Introduction of infected animals is the most important route of
transmission of MAP between herds (Rangel et al., 2005). Frequent
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cattle purchases from other herds without knowledge of their dis-
ease status increased the risk for MAP culture-positive environmen-
tal samples (Wolf, Barkema, De Buck, & Orsel, 2016). Although
testing animals pre-purchase will prevent the introduction of positive
animals, the long incubation period will result in many false-negative
cattle. Thus, herd-level testing of the herd of origin in a certification-
and-surveillance programme (Weber, Groenendaal, van Roermund, &
Nielen, 2004; Weber, van Roermund, Vernooij, Kalis, & Stegeman,
2006) is likely to be more effective in reducing the risk associated
with the trade of cattle between herds. Although MAP can survive
for a long time in water (Elliott et al., 2015), the role of transmission
through surface and drinking water is not known, and there are
many unknowns about the role of transmission from other ruminants
and wildlife to domestic ruminants (Table 1).
6.7 | Between-species transmission
Cross-grazing sheep and deer reduces the risk of clinical paratuber-
culosis in deer because the sheep strain of MAP is less pathogenic
for deer than the cattle strain (Heuer et al., 2012; Verdugo, Pleydell,
et al., 2014). Modelling exercises have shown that the similarity of
strain types isolated from beef cattle and deer was 3-fold greater
when direct contact between these species was considered com-
pared to a scenario that ignored the contact structure. Transmission
would be expected to go in both directions between co-grazed ani-
mals, thus grazing infected deer with sheep or cattle puts both spe-
cies at risk. In the UK, the presence of farmed deer increased the
risk of reporting clinical JD in dairy cattle kept on the same farm
(ORs ranged from 15 to 209; Cetinkaya, Erdogan, & Morgan, 1997).
In many areas, there is co-grazing of wildlife and domestic live-
stock, which may allow cross-infection to occur under specific condi-
tions (high animal density, neonates in population, etc.). In an alpine
region in Italy, MAP-infected ibex are sympatric with seropositive
cattle (Ferroglio, Nebbia, Robino, Rossi, & Rosati, 2000). In Spain,
cattle, sheep and goats share pastures and waterholes with herds of
fallow deer in which paratuberculosis has been diagnosed (Balseiro,
Garcıa Marın, Solano, Garrido, & Prieto, 2008). In Germany, it
appears that feral and farmed animals are reservoirs for specific
MAP genotypes (Fritsch et al., 2012). Although other studies failed
to demonstrate significant transmission between wildlife and live-
stock, false negatives can be common. It is important to keep in
mind that many wildlife studies have limited observations and with
that, limited power (Table 1). Also, there is no uniformity in MAP
diagnostics which makes it challenging to compare studies from
around the world (Table 1).
7 | ROLE OF WILDLIFE
A better understanding of the epidemiology of MAP in wildlife is
essential for implementing effective disease prevention and infection
control programmes for livestock. MAP has been recovered from a
wide variety of wildlife species worldwide (with or without signs of
JD). Mostly, it has been found in wild ruminants (reviewed by Mack-
intosh & Griffin, 2010); however, other species such as lagomorphs
may have an important role in MAP transmission (reviewed by
Hutchings et al., 2010). Regardless, much remains to be learned
about the distribution of MAP among free-ranging wildlife popula-
tions, impacts of infection on the health of these populations, poten-
tial for these populations to act as reservoirs for MAP and the
extent of MAP transmission between wildlife and livestock in various
environments (Table 1).
For most wildlife surveillance efforts, resources are scant.
Current methods that reduce the cost of diagnostic testing, such
as pooled faecal culture, have only been validated for cattle (Van
Schaik et al., 2007). Commercially available ELISA tests require
validation prior to their use for MAP surveillance in specific wild-
life species (Pruvot et al., 2013). Furthermore, it is difficult to
sample wildlife populations, particularly to obtain high-quality
random samples, which negatively affects the quality of diagnos-
tic results.
Although it has never been quantified, transmission from wildlife
is considered a very low risk. Regardless, the livestock industry has
opportunities to mitigate the likelihood of inter-species interactions;
covering feed storage, keeping wildlife away from forage feeders
and other attractants on the farm, and fencing ponds reduced the
frequency with which wildlife visit livestock premises (Van Campen
& Rhyan, 2010). The livestock industry could be motivated to pro-
actively keep wildlife away from livestock if there were well-docu-
mented financial benefits. There is limited information available on
disease introductions of endemic pathogens through wildlife
(Table 1), and most published models focus on introductions of
emerging and notifiable diseases with huge financial impact (e.g.,
tuberculosis and foot-and-mouth disease).
The main limitation in considering the role of wildlife species is
understanding the circulation of MAP at the livestock–wildlife inter-
face and identifying elements that allow certain wildlife populations
to maintain MAP infection and potentially act as a reservoir for live-
stock. Certainly, it should not be assumed that sympatric wildlife and
domestic cattle populations always exchange infection (e.g., Whit-
tington, Marsh, & Whitlock, 2001). Increased knowledge on these
aspects of the epidemiology of MAP would contribute to our under-
standing of infection dynamics and may improve JD control pro-
grammes (Table 1). Unfortunately, with current limited funding
opportunities for wildlife-focused studies, as well as the challenges
of designing appropriate multidisciplinary studies, these answers
might not be easily generated.
Studies to date investigating the possibility of inter-species
MAP transmission involving wildlife have focused simply on the
presence or absence of shared strains. None have analysed the
degree, directionality of transmission or incidence of infection
caused by spillback or spillover. Therefore, a genotyping scheme
with an appropriate level of discriminatory power, implemented
within a well-designed sampling scheme, is essential for reliably
investigating the role of wildlife in the epidemiology of MAP
(Fritsch et al., 2012) (Table 1).
134 | BARKEMA ET AL.
8 | SUSCEPTIBILITY
8.1 | Age
Dairy calves are exposed to MAP by the manure from infected adult
cattle that shed the bacteria and contaminate water and feed
(McKenna, Vanleeuwen, et al., 2006). Greater permeability of the
neonatal intestine facilitated MAP entry (Sweeney, 1996), whereas
there was increased resistance with age due to repeated exposure
to the organism (Delgado et al., 2013) and the dilution effect of the
growing rumen (Windsor & Whittington, 2010). However, in an
experimental infection trial with 50 calves inoculated at 2 week, 3,
6, 9 or 12 month of age, calves were equally susceptible to infection
with MAP up to 1 year of age, based on antibody production, faecal
shedding, IFN-c response, pathology and tissue culture (Mortier, Bar-
kema, & De Buck, 2015; Mortier et al., 2013; Mortier, Barkema, Wil-
son, et al., 2014; Mortier, Barkema, Orsel, Wolf, et al., 2014;
Mortier, Barkema, Orsel, Wolf, De Buck, et al., 2014). Additionally,
infection of non-lactating heifers (1–2 year old) occurred when graz-
ing on pasture contaminated with MAP (Fecteau et al., 2010). There-
fore, although susceptibility of MAP infection clearly decreases with
increasing age (Windsor & Whittington, 2010), control programmes
should, depending on the purpose of the programme, consider
including cattle of all ages (Table 1).
Although likely animals of all ages can be infected with MAP, age
at infection seems to affect immune responses, faecal shedding and
lesions at necropsy. Calves inoculated at 3 month of age shed more
frequently and had a more robust humoral immune response and
more severe lesions at necropsy than calves inoculated at an older
age, or at the same age but with a low dose (Mortier, Barkema, Wil-
son, et al., 2014; Mortier, Barkema, Orsel, Wolf, et al., 2014). The
cellular immune response was less marked in calves inoculated at
2 week of age than calves inoculated later in life (Mortier, Barkema,
Orsel, Wolf, De Buck, et al., 2014), consistent with the need for a
strong cellular immune response to confer better protection against
infection (Stabel, 2006). In sheep, age of exposure also strongly
affected the outcome of MAP infection, with lambs infected earlier
in life starting to shed sooner, having more severe pathology and
higher mortality rate (McGregor et al., 2012).
A strong initial cellular immune response, possibly in combination
with humoral immunity, appeared to be key to controlling progres-
sion of JD (Stabel, 2006). Therefore, infection at a young age when
the immune system is still immature and less effective (Chase, Hur-
ley, & Reber, 2008) generally caused more severe lesions. Therefore,
age at the time of infection affected the consequences of MAP
infection. In a study analysing shedding patterns in naturally infected
cows, it was clear that the majority of studied cows never developed
high-shedding levels (Mitchell et al., 2015). Those that did, typically
never reduced their shedding level to low or no shedding. Cows that
eventually became high shedders had a pattern of continuous shed-
ding. In contrast, cows with an intermittent shedding pattern had a
low probability to ever become high shedders. In addition, cows that
start shedding at a younger age (less than 3 years of age) have a
lower hazard of becoming high shedders compared to cows starting
to shed at an older age. These data suggest the presence of three
categories of immune control. Cows that are intermittent shedders
have the infection process under control (no progressive infection).
Cows that start shedding persistently at a young age partially control
the infection, but eventually will be high shedders (slow progressive
infection), whereas cows that start shedding persistently at an older
age cannot effectively control the infection and become high shed-
ders rapidly (Mitchell et al., 2015). However, little more is known
about factors influencing the course of MAP infection.
8.2 | Heritability of susceptibility and resistance
Quantitative genetic studies predominantly performed in Holstein-
Friesian cows have demonstrated that genetics play an important
role in susceptibility to JD, and their heritability estimates indicate
that the genetic basis of JD is likely a multigenic trait (Gonda, Chang,
Shook, Collins, & Kirkpatrick, 2006; Koets et al., 2000). Channel
Island cattle breeds are 1.4–8.3 times more likely to test positive for
MAP compared to other dairy breeds (Cetinkaya et al., 1997; Nor-
ton, Heuer, & Jackson, 2009; Sorge et al., 2011). Outbreaks of JD
occur in beef herds, but the prevalence of MAP infection is much
lower than in dairy herds. Bos indicus purebreds and cross-breeds
have odds ratios 17-fold and 3.5-fold greater than Bos taurus breeds
for positive ELISA results (Roussel et al., 2005). Despite likely differ-
ences due to management (intensively farmed housed dairy cattle vs.
extensively beef cattle kept on large pastures), the lower prevalence
in beef cattle may also be the result of lower genetic susceptibility
of some beef cattle breeds (Table 1). Genetics as an approach to dis-
ease control is an emerging discipline. Identifying the genetic basis
of the lower susceptibility will provide possibilities for selection for
resistance to MAP infection in dairy and beef cattle, as has been
done with Red deer (Dobson, Liggett, O’Brien, & Griffin, 2013).
While genetic improvement for disease resistance is slow, the results
are permanent (van Hulzen et al., 2014; Kirkpatrick & Shook, 2011).
There is good evidence in a range of ruminant species for genetic
influence on susceptibility to mycobacterial infections (Kirkpatrick &
Shook, 2011).
Heritability of test positivity for MAP infection in cattle ranges
from 0.041 to 0.159 (Attalla, Seykora, Cole, & Heins, 2010; Gonda
et al., 2006; Hinger, Brandt, Horner, & Erhardt, 2007; van Hulzen
et al., 2011; Koets et al., 2000), indicating that part of the variability
in response to exposure in the population is due to genetics
(Table 1). Multiple recent studies also clearly suggest that suscepti-
bility to MAP infection is multigenic or polygenic. The effect of
genetic polymorphisms in candidate genes was recently reviewed
(Kirkpatrick & Shook, 2011) as well as linkage analysis of genetic
susceptibility using genomewide association studies (GWAS; Purdie,
Plain, Begg, de Silva, & Whittington, 2011). Limited congruence
between studies was attributed to: (i) definitions of case and control;
(ii) phenotypic data recorded (tissue culture, faecal culture, blood
ELISA, milk ELISA); and (iii) variability in diagnostic methods used
between cattle at the same stage of infection.
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The host response to MAP can be categorized as susceptible,
resistant or tolerant. Attempts to locate loci associated with resis-
tance to paratuberculosis have proven to be more challenging than
finding loci associated with susceptibility. A major problem for inves-
tigating the influence of genetics on susceptibility against MAP
infection is the difficulty in accurately classifying susceptible, resis-
tant or tolerant animals. For example, it is yet unknown whether
selection against ELISA positivity results in offspring more resistant
to (progression of) the infection, or in offspring that is unable to
mount an ELISA response given infection.
There is also an inherent uncertainty in phenotypes, due to the
low sensitivity of diagnostic tests for MAP infection. Heritability esti-
mates for resistance to JD are higher when faecal culture is used
versus ELISA (Kupper, Brandt, Donat, & Erhardt, 2012). Possible
genetic influences on host immunological responses could be a con-
founding factor (Table 1).
A comprehensive GWAS study (Settles et al., 2009) identified
genetic loci associated with four phenotypes: presence of MAP in
the tissues, presence in faeces, presence in both tissues and faeces,
and presence in tissues but not in faeces. Based on the identification
of loci associated with these groups, distinct loci may be important
to specific stages of the disease. As different genes are associated
with different steps in the infection and disease processes, it is
expected that different diagnostics will identify different susceptibil-
ity genes corresponding to the observed phenotype. Misclassification
can be avoided to some extent by parallel test interpretation.
So far, the IFN-c assay has not been applied in genetic linkage
studies. While it is debatable whether a positive test corresponds
with active MAP infection or is the only evidence of exposure, it is
likely that, in combination with other diagnostics, this additional
information would help identify different phenotypes, particularly
the resistant type (Table 1). Ideally, other biomarkers (e.g., transcrip-
tomics) would be used to identify susceptible animals. For this pur-
pose, biomarker outcomes need to be analysed with knowledge of
the genetic make-up of exposed animals.
Consolidation of marker-assisted breeding approaches for protec-
tion of animal populations against paratuberculosis is the ultimate
goal of genetic studies. Animal selection based on marker-assisted
breeding might lead to cattle populations with enhanced disease
resistance and favourable vaccine responses by stimulating protec-
tive immune responses (Fisher et al., 2011). However, before these
markers can be used to guide selection, undesirable genetic linkages
need to be identified. Such a counterproductive linkage occurred
when high milk production was genetically associated with slightly
increased susceptibility to MAP (Shook, Chaffer, Wu, & Ezra, 2012).
In addition, genetic linkage studies can be expanded from identifying
direct associations with susceptibility to infection to associations
(e.g., likelihood of progression to clinical disease, specific responses
to vaccination or tendency to progress to supershedding) (Table 1).
It is not surprising that studies of genetic influence on JD sus-
ceptibility of cattle have not had consistent outcomes (Table 1).
Apparent causes include size of the study, population structures,
markers used and case definitions. Because cattle populations often
have a high level of relatedness, the hidden presence of closely
related animals in a sample would cause an a priori unequal distribu-
tion of allele frequencies between cases and controls, which could
inflate the rate of false-positive associations between trait and mar-
ker (Minozzi et al., 2012). This calls for collaborative cross-border
experimental designs, use of appropriate statistical models when
analysing genetic data and awareness of the genetic structure of the
population under study. An initial combined analysis of two distinct
populations, in which different phenotypic definitions were used,
resulted in discovery of novel putative genetic markers for suscepti-
bility (Minozzi et al., 2012).
Future case–control studies should consider limitations of diag-
nostic tests and lack of knowledge on the family structure of the
study objects. However, alternatives to case–control studies exist
and involve cohort study design (classifying animals according to
genotype), with disease outcome being determined after a period
sufficient for signs/tests of disease to become apparent and be accu-
rately determined in a longitudinal study (Purdie et al., 2011).
Regardless, large numbers of animals are needed to detect small dif-
ferences in susceptibility due to specific gene loci.
Now that multiple SNPs have been associated with susceptibility
to MAP infection, a series of follow-up experiments are important
next steps, the so-called post-GWAS functional characterization of
susceptibility variants. Detailed molecular studies to determine the
function of the specific nucleotide substitutions mechanistically
should follow. Next, experimental infection trials with specific geno-
types could be envisioned which would investigate actual effects on
infection dose, susceptibility age, diagnostic outcomes, immune
responses, immune cell profiles, etc. (Table 1).
Much effort has been spent identifying a connection between
host genotype and susceptibility to MAP infection. However, a por-
tion of the variation in disease manifestation and progression might
also be correlated with different MAP genotypes (Table 1). Perhaps
specific MAP genotypes associate with a specific host genotype.
However, such multilevel genotype linkage analyses have not been
carried out.
9 | VACCINATION
The Gudair vaccine has been widely applied in Australian sheep
herds and has become the dominant JD control practice. Using this
killed vaccine reduced the prevalence of MAP infection and faecal
shedding, and mortality in Australian sheep herds considerably
(Dhand, Eppleston, Whittington, & Windsor, 2016; Reddacliff, Epple-
ston, Windsor, Whittington, & Jones, 2006). This vaccine does not
prevent MAP infection and can therefore not be used on its own to
eradicate MAP infection. In contrast to sheep, in cattle no effective
vaccine is available, and the lack of an efficacious vaccine that pro-
tects against infection with MAP is hampering control programmes.
Existing JD cattle vaccines can reduce clinical impacts of infection,
including sometimes reduced shedding, but they do not prevent
infection. Additional obstacles are interference with tests to identify
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animals infected with other mycobacterial species (e.g., M. bovis) and
that they can cause severe reactions at the injection site (Kalis, Hes-
selink, Barkema, & Collins, 2001). Therefore, there is clearly a need
for better vaccines in addition to improved diagnostic tests for JD
(Table 1).
Ideally, a MAP vaccine would protect against infection, keeping
negative herds MAP-free and safeguard young and susceptible ani-
mals in high-prevalence herds. Arguably, such an ideal vaccine could
be live attenuated, can be administered orally, is sufficiently virulent
to trigger protective cell-mediated immune responses, protects
exposed animals against infection at the tissue level, is cleared rela-
tively quickly from the vaccinated animal, can be differentiated from
wild type strains, is not spread to other animals, protects against
homologous and heterologous strains and generates immune
responses that can be differentiated from M. bovis infections and
ideally also from natural MAP infections (with appropriate diagnostic
tests).
Current vaccines may partially reduce infectiousness or shedding
load, prolong the latent period of infected animals, slow progression
from low shedding to high shedding or decrease the cumulative inci-
dence of clinical JD cases; however, they are not effective in pre-
venting infection (Alonso-Hearn et al., 2012; Kalis et al., 2001;
Kathaperumal et al., 2008; Kormendy, 1992; Romano & Huygen,
2009; Rosseels & Huygen, 2008; Santema, Hensen, Rutten, & Koets,
2009; Wentink, Bongers, Zeeuwen, & Jaartsveld, 1994). Bacterin
vaccines, subunit vaccines (Faisal et al., 2013; Hoek, Rutten, van der
Zee, Davies, & Koets, 2010; Koets et al., 2006; Thakur, Aagaard,
Stockmarr, Andersen, & Jungersen, 2013) and vector vaccines (Bull
et al., 2014; Roupie et al., 2012) have also been created, but have
been less effective than expected. Their inability to prevent the
establishment of infection leaves the potential for infected animals
to break with disease if protective immunity wanes. Subunit vaccines
have been reported to provide incomplete protection in murine
models (Stabel, Barnhill, Bannantine, Chang, & Osman, 2012) or
ruminant models (calves and goats) of infection (Kathaperumal et al.,
2008, 2009; Koets et al., 2006). In addition, other subunit vaccines
(Facciuolo & Mutharia, 2014; Gurung, Begg, Purdie, & Whittington,
2013; Johnston et al., 2014) are being proposed as having potential
to prevent infection. Most vaccines have been tested in a preventive
pre-exposure setting. However, as calves are commonly born into
herds with endemic MAP infection and a MAP-contaminated envi-
ronment, post-exposure strategies should also be considered (San-
tema et al., 2013).
Globally, most current vaccines are based on MAP strain 316F
formulated in mineral oil adjuvant, either as a live (Neoparasec) or
dead strain (Mycopar, ID-Lelystad, Gudair, Silirum). Only Mycopar is
licensed in the United States and used on only 5% of US dairy oper-
ations (Cho et al., 2012) and under strict control of local veterinary
authorities, as vaccinated cattle are more likely to be false positive
on a standard bovine tuberculosis test (Muskens, van Zijderveld,
Eger, & Bakker, 2002). The single intradermal tuberculin test is still
the most widely used tuberculosis diagnostic test in cattle (Bastida &
Juste, 2011). However, modification of the test, whereby two sites
are injected with either tuberculin from M. bovis or MAP and a dif-
ference in reactivity is recorded, has already been shown to solve
the M. bovis interference problem in the vast majority of cases. This
comparative intradermal tuberculin test has been available for many
years and is an official test according to OIE and EU legislation (Bas-
tida & Juste, 2011). So, false-positive M. bovis detection can be elim-
inated when next-generation vaccines are accompanied by
compatible diagnostics (Table 1).
A critical aspect in the development of MAP vaccines is the pro-
tective immune responses they are supposed to elicit. The precise
nature of a protective immune response is still to be determined
(Table 1). An advantage of live-attenuated vaccines (LAV) is that
they will stimulate both cell-mediated and humoral immune
responses (Faisal et al., 2013; Park et al., 2011). Cell-mediated
immune responses have been associated with protection (Settles,
Kink, & Talaat, 2014; Stabel & Robbe-Austerman, 2011), and there-
fore, it has been postulated that if a LAV MAP vaccine could drive
the immune response to a pro-inflammatory Th1 profile and prevent
a shift to the humoral Th2 response, it might be more effective in
delaying disease progression (Coussens, 2004; Stabel & Robbe-Aus-
terman, 2011). In sheep, specific lymphocyte subsets play a role in
protecting against MAP infection, including sheep vaccinated with
killed vaccine (de Silva, Plain, Begg, Purdie, & Whittington, 2015).
Although LAV induced strong protection in a mouse model (Ghosh,
Shippy, & Talaat, 2015), in a goat model they showed no protective
efficacy in some studies (Hines et al., 2014; Park, Allen, Barrington,
& Davis, 2014) and strong reduction in shedding in a recent other
study (Shippy et al., 2017); they have apparently not been tested in
cattle.
The appropriate level of attenuation of LAV strains has not been
established (Table 1). However, it is clear from past experiences that
these models should not be restricted to in vitro experimentation or
mouse models (Bannantine et al., 2014). Furthermore, single knock-
out strains may not be optimal vaccine candidates because they may
not be attenuated enough to stimulate the protective immune
response without causing disease. Although a 1-gene knockout (KO)
might yield a strain that cannot persist in the animal and/or environ-
ment and therefore not pose an infectious risk to spread and cause
disease, a second attenuation should be introduced to eliminate the
manipulative mechanisms that inhibit or counteract protected
immune responses. So, a vaccine strain should not only trigger pro-
tective immune responses but also avoid immune modulation path-
ways to be activated, which will allow a wild type (WT) strain to
establish an infection and ensure that the immune evasion strategies
of MAP are rendered neutral.
Selection of the first type of essential gene can be carried out by
screening transposon mutant libraries for an optimal LAV (Rathnaiah
et al., 2014; Wang, Pritchard, Kreitmann, Montpetit, & Behr, 2014),
ideally in a ruminant host. However, selection of the second type of
KO requires further study of pathogenesis in in vitro and in vivo
models. We need a better understanding of the immune evasion and
immune modulation strategies that MAP clearly is capable of (Arse-
nault et al., 2014) (Table 1). Due to these immune evasion
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properties, MAP can subvert both the induction of acquired immune
responses and cell-mediated responses. Reasons for these are poten-
tially 2-fold: First, because the LAV vaccine will have retained these
immune evasion properties and therefore elicit inadequate immune
responses; and secondly, because an infecting WT strain will be able
to subvert immune responses generated by a vaccine. A future pro-
tective vaccine may need to prevent or counteract these evasion
mechanisms.
9.1 | Diagnostic aspects of vaccination
Differentiation of infected and vaccinated animals (DIVA) is an
important consideration. When using a subunit vaccine approach,
DIVA can be obtained as has been shown in cattle vaccinated with
a subunit vaccine against MAP (Santema et al., 2009). None of the
three currently commercially available killed vaccines or LAV lend
themselves well to DIVA, although engineered vaccine strains
might be better. Complementary diagnostics will have to be devel-
oped to incorporate DIVA in an integrated platform of new diag-
nostic and vaccination strategies, particularly to differentiate
M. bovis infections from JD vaccination (Table 1). Next-generation
diagnostics for MAP infection will likely measure early cell-
mediated immune responses. Immune responses against this posi-
tive marker of extraneous nature would clearly demonstrate that
animals were vaccinated (Table 1). A negative marker, being an
immunodominant antigen that is “deleted” from the vaccine strain,
could be implemented in novel M. bovis diagnostics next to anti-
gens specific for M. bovis (e.g., ESAT-6/CFP-10 and Rv3615c) (De
Val et al., 2012). Thus, the problematic interference with M. bovis
testing could be completely mitigated with a marked vaccine and
compatible diagnostics.
Following complementary diagnostics for DIVA purposes, new
biomarkers that act as correlates of protection and/or that indicate
lack of protection are necessary for screening, development and
testing of novel MAP vaccine candidates (de Silva et al., 2015). So
far, good correlates of protection have remained elusive.
From exercises modelling impacts of imperfect MAP vaccines,
it was concluded that vaccination should be integrated into a com-
prehensive control programme that includes test-and-cull interven-
tion and improved calf rearing management (Bush, Windsor,
Toribio, & Webster, 2008; Cho et al., 2012). Cost-benefit analysis
of vaccination against MAP in dairy cattle was performed (Groe-
nendaal, Zagmutt, Patton, & Wells, 2015). Vaccination was benefi-
cial by reducing the frequency of heavy shedders and clinically
affected animals. A meta-analysis also concluded that vaccination
against MAP is a valuable tool in reducing MAP contamination
risks and reducing or delaying production losses (Bastida & Juste,
2011).
Newly developed vaccines will need to be well characterized to
fully understand their risks and benefits. For example, the risk of
shedding in vaccinated cattle needs to be investigated, as was done
in sheep vaccinated with the Gudair vaccine (Windsor, Eppleston,
Dhand, & Whittington, 2014).
The success of a LAV vaccine will depend on which MAP strain
is selected to generate the vaccine (~parent strain). Vaccine strains
will likely have to be sufficiently homologous in antigen composition
with the majority of field strains. In India, a vaccine based on a
regional strain variant was more effective than a commercial JD vac-
cine (Singh et al., 2013). In our view, there should be a focused
effort to characterize the diversity of MAP strains (Table 1). Geno-
typic and phenotypic variation needs to be investigated to derive
quantitative and qualitative understanding of this diversity around
the world.
10 | UPTAKE
Nearly all JD prevention and control programmes worldwide are vol-
untary, and their success depends on enrolment and retention, along
with sufficient uptake of recommended best management practices.
To establish high participation rates, JD control programmes need to
account for farmers’ motivators and barriers to enrol and implement
recommended management changes (Table 1). In recent years, farm-
ers’ “mindset” and its influence on behaviour have become an impor-
tant focus of research (e.g., Derks, van de Ven, van Werven, Kremer,
& Hogeveen, 2012; Garforth, 2015; Jansen & Lam, 2012; Roche,
Jones-Bitton, Meehan, Von Massow, & Kelton, 2015). Farmers’ atti-
tudes and beliefs towards the disease and the proposed approach
for disease control have important roles in their motivation to
adhere to suggested management strategies (Ritter et al., 2017). This
relatively new avenue of research has important implications for our
approaches to motivating individual farmers to adopt optimal JD
management practices. Farmers’ considerations such as improved
herd health and concern over consumer health can be important
motivators to participate in JD control or certification programmes
(Kovich, Wells, & Friendshuh, 2006; Nielsen, 2011; Roche, 2014).
External incentives can also be an important driver to control MAP;
a decision analysis from the farmers perspective indicated that a
milk-price differentiation of only 0.005/kg milk was sufficient to
make enrolment of Dutch dairy farmers in a control programme
attractive (Velthuis, Weber, Koeijer, & Van Roermund, 2006). How-
ever, management constraints (e.g., limited time or finances) and the
perceived complexity of JD control programmes can be critical
impediments for uptake of biosecurity measures (Rossiter & Burhans,
1996; Sorge et al., 2010; Wraight et al., 2000), and often farmers
prefer to “wait-and-see” how the JD control programme works on
other farms before they enrol (Ritter et al., 2015) (Table 1).
Several studies reported that farmers rely on various sources to
obtain their farm management information and should be
approached according to their specific needs to ensure successful
knowledge uptake (Heffernan, Nielsen, Thomson, & Gunn, 2008;
Jansen, van Schaik, Renes, & Lam, 2010; Russell & Bewley, 2011). In
particular, herd health veterinarians have been regarded as trustwor-
thy and reliable sources of advice on disease and disease risk man-
agement (Brennan & Christley, 2013; Ellis-Iversen et al., 2010).
Because of this key role veterinarians play in farmers’ management
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decisions, it is important to employ them as mediators between
industry and farmers. However, veterinary practitioners’ attitudes
towards JD control are often unknown and the extent to which they
actively promote enrolment in JD control programmes and/or indi-
vidual on-farm changes to reduce MAP transmission remains unclear
(Table 1). Even farmers provided with veterinary advice on JD con-
trol often implemented less than half of the suggestions made (Sorge
et al., 2010; Wraight et al., 2000). Miscommunication between dairy
practitioners and farmers is likely an important cause of the lack of
uptake. For example, veterinarians did not assess producers’ expec-
tations sufficiently but provided them with too many, potentially
overwhelming, suggestions (Sorge et al., 2010). These apparent gaps
in veterinary–farmer communication need to be addressed.
More recent applied research has investigated best practices for
communicating with producers and motivating on-farm change, often
employing group-based and peer learning approaches. Many of these
efforts have emphasized the importance of the veterinarian for mak-
ing tailored on-farm recommendations, but have also promoted the
use of facilitators to better understand and respond to producer
mindset. Recent examples from Australia (Kingham & Links, 2012),
Denmark (Trier, Nielsen, & Krogh, 2012) and Canada (Roche et al.,
2015) have yielded promising results for motivating on-farm change
towards effective JD prevention and control.
In addition to a lack of knowledge regarding the discussion of JD
control with producers, communication strategies used to inform
decision-makers in government and policy authorities, farmer organi-
zations and breeding associations are still unclear. Researchers’
responsibility is to provide information that enables evidence-based
decisions, for example, regarding JD certification and trade regula-
tions. Clear communication between researchers, farmer organiza-
tions and authorities creating evidence-based policy will likely
increase motivation to initiate and continue control programmes and
improve policy acceptance and uptake by farmers.
Johne’s disease is only one of many faecal-orally transmitted
infectious diseases in cattle. Measures to prevent infection with
MAP will likely also have positive effects on the incidence of infec-
tion with Salmonella spp., Cryptosporidium parvum and Cryptosporid-
ium bovis, Escherichia coli, and rota- and corona virus (McKenna,
Keefe, et al., 2006). Often, the latter bacteria cause more obvious
clinical signs than MAP and convince the farmer of the presence and
severity of illness. These “cues-to-action” might enhance farmers’
openness to improve suboptimal management practices. Therefore,
addressing calf health and biosecurity more holistically could help
motivate producers that currently do not perceive JD control as high
priority (Table 1).
11 | CONCLUSIONS
Nearly a century of JD control programmes has, particularly in the
dairy industry, not resulted in sufficient progress. Except for goats in
Norway, no reports can be found in a herd in which MAP infection
has been eradicated, and in many countries, herd- and animal-level
prevalence has not decreased. As a result, JD continues to cause con-
siderable losses to the livestock industry. The insufficient progress
has been the result of gaps in our knowledge about this difficult dis-
ease. Research has focused on test development and evaluation, vac-
cine development, and design and evaluation of management
strategies to prevent MAP infection. Many of the knowledge gaps
identified are in these areas (Table 1). However, the authors are opti-
mistic that if sufficient progress can be made addressing these knowl-
edge gaps, progress in the control of this insidious disease in the next
decades will be better. The introduction of a JD vaccine has made a
huge impact in the Australian sheep industry. Development of a JD
vaccine with accompanying diagnostic tests that prevents infection
and shedding and does not impair tuberculosis diagnostics remains 1
of the most pressing gaps for the livestock industry. Reliably and pro-
actively (pre-shedding) identifying infected animals that will very
likely shed the pathogen, potentially involving biomarkers, is another
research priority. Susceptibility for MAP infection differs among
breeds. Identification of genetic markers that distinguish very suscep-
tible from more resistant animals has the potential to advance JD
control. Quantification of the role of calf-to-calf transmission will be
necessary to improve cattle control programmes. Uptake of JD con-
trol programmes will improve if these knowledge gaps have been sat-
isfactorily addressed. However, because of the voluntary nature of
JD programmes, it will still be important to identify factors that moti-
vate farmers to enrol in these programmes.
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